DELIGNIT AG (DLX.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:DLX • DE000A0MZ4B0

2.74 EUR
+0.28 (+11.38%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

DLX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 12 industry peers in the Paper & Forest Products industry. Both the profitability and the financial health of DLX get a neutral evaluation. Nothing too spectacular is happening here. DLX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DLX had positive earnings in the past year.
  • DLX had positive earnings in each of the past 5 years.
  • DLX had a positive operating cash flow in 4 of the past 5 years.
DLX.DE Yearly Net Income VS EBIT VS OCF VS FCFDLX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • DLX has a Return On Assets (1.77%) which is comparable to the rest of the industry.
  • DLX has a Return On Equity (2.33%) which is comparable to the rest of the industry.
  • DLX has a Return On Invested Capital of 2.11%. This is in the lower half of the industry: DLX underperforms 75.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DLX is in line with the industry average of 5.34%.
  • The 3 year average ROIC (6.49%) for DLX is well above the current ROIC(2.11%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROIC 2.11%
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
DLX.DE Yearly ROA, ROE, ROICDLX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • The Profit Margin of DLX (1.39%) is comparable to the rest of the industry.
  • DLX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 1.99%, DLX is doing worse than 75.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DLX has declined.
  • DLX's Gross Margin of 43.73% is fine compared to the rest of the industry. DLX outperforms 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of DLX has grown nicely.
Industry RankSector Rank
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
DLX.DE Yearly Profit, Operating, Gross MarginsDLX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • DLX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, DLX has about the same amount of shares outstanding.
  • The number of shares outstanding for DLX has been increased compared to 5 years ago.
  • Compared to 1 year ago, DLX has an improved debt to assets ratio.
DLX.DE Yearly Shares OutstandingDLX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DLX.DE Yearly Total Debt VS Total AssetsDLX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 3.98 indicates that DLX is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.98, DLX belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that DLX is not too dependend on debt financing.
  • DLX has a better Debt to Equity ratio (0.03) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.98
ROIC/WACC0.28
WACC7.44%
DLX.DE Yearly LT Debt VS Equity VS FCFDLX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • DLX has a Current Ratio of 4.14. This indicates that DLX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.14, DLX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • DLX has a Quick Ratio of 1.86. This is a normal value and indicates that DLX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.86, DLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 1.86
DLX.DE Yearly Current Assets VS Current LiabilitesDLX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • DLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.89%.
  • DLX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.22% yearly.
  • DLX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.67%.
  • DLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.24% yearly.
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%

3.2 Future

  • Based on estimates for the next years, DLX will show a very strong growth in Earnings Per Share. The EPS will grow by 41.22% on average per year.
  • Based on estimates for the next years, DLX will show a small growth in Revenue. The Revenue will grow by 7.81% on average per year.
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y7.81%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLX.DE Yearly Revenue VS EstimatesDLX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
DLX.DE Yearly EPS VS EstimatesDLX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 34.25 indicates a quite expensive valuation of DLX.
  • Compared to the rest of the industry, the Price/Earnings ratio of DLX is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of DLX to the average of the S&P500 Index (27.92), we can say DLX is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 10.05, which indicates a very decent valuation of DLX.
  • Based on the Price/Forward Earnings ratio, DLX is valued a bit cheaper than 75.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DLX to the average of the S&P500 Index (27.78), we can say DLX is valued rather cheaply.
Industry RankSector Rank
PE 34.25
Fwd PE 10.05
DLX.DE Price Earnings VS Forward Price EarningsDLX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DLX indicates a somewhat cheap valuation: DLX is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.06
DLX.DE Per share dataDLX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • DLX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • DLX's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • DLX has a Yearly Dividend Yield of 2.03%.
  • DLX's Dividend Yield is comparable with the industry average which is at 3.05.
  • DLX's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

  • The dividend of DLX is nicely growing with an annual growth rate of 11.75%!
Dividend Growth(5Y)11.75%
Div Incr Years0
Div Non Decr Years0
DLX.DE Yearly Dividends per shareDLX.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2023 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

  • DLX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%
DLX.DE Yearly Income VS Free CF VS DividendDLX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

More info and screens

Find the best dividend stocksShow peers with best dividend

DELIGNIT AG

FRA:DLX (2/6/2026, 7:00:00 PM)

2.74

+0.28 (+11.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-26
Earnings (Next)04-27
Inst Owners64.53%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.06M
Revenue(TTM)62.14M
Net Income(TTM)863.00K
Analysts84
Price Target5.51 (101.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend0.08
Dividend Growth(5Y)11.75%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10%
PT rev (3m)-10%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 34.25
Fwd PE 10.05
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.82
EV/EBITDA 6.06
EPS(TTM)0.08
EY2.92%
EPS(NY)0.27
Fwd EY9.95%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.07
BVpS3.62
TBVpS3.34
PEG (NY)1.26
PEG (5Y)N/A
Graham Number2.55
Profitability
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROCE 2.98%
ROIC 2.11%
ROICexc 2.64%
ROICexgc 2.9%
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
FCFM N/A
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
ROICexc(3y)7.91%
ROICexc(5y)8.19%
ROICexgc(3y)8.82%
ROICexgc(5y)9.23%
ROCE(3y)9.19%
ROCE(5y)9.93%
ROICexgc growth 3Y-25.04%
ROICexgc growth 5Y-10.87%
ROICexc growth 3Y-24.73%
ROICexc growth 5Y-10.11%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
F-ScoreN/A
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.32
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 1.86
Altman-Z 3.98
F-ScoreN/A
WACC7.44%
ROIC/WACC0.28
Cap/Depr(3y)125.11%
Cap/Depr(5y)92.99%
Cap/Sales(3y)3.97%
Cap/Sales(5y)3.03%
Profit Quality(3y)140.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y7.81%
EBIT growth 1Y-53.75%
EBIT growth 3Y-22.99%
EBIT growth 5Y-7.31%
EBIT Next Year160%
EBIT Next 3Y71%
EBIT Next 5Y54.93%
FCF growth 1Y-37.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3YN/A
OCF growth 5Y21.67%

DELIGNIT AG / DLX.DE FAQ

What is the fundamental rating for DLX stock?

ChartMill assigns a fundamental rating of 5 / 10 to DLX.DE.


Can you provide the valuation status for DELIGNIT AG?

ChartMill assigns a valuation rating of 5 / 10 to DELIGNIT AG (DLX.DE). This can be considered as Fairly Valued.


How profitable is DELIGNIT AG (DLX.DE) stock?

DELIGNIT AG (DLX.DE) has a profitability rating of 4 / 10.


What is the valuation of DELIGNIT AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DELIGNIT AG (DLX.DE) is 34.25 and the Price/Book (PB) ratio is 0.76.


Can you provide the financial health for DLX stock?

The financial health rating of DELIGNIT AG (DLX.DE) is 6 / 10.